tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Microbot Medical Selected for Russell Microcap Index

Story Highlights
  • Microbot Medical is included in the preliminary list for the Russell Microcap® Index.
  • This inclusion may increase the company’s visibility among investment managers and investors.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Microbot Medical Selected for Russell Microcap Index

Elevate Your Investing Strategy:

Microbot Medical ( (MBOT) ) has issued an update.

On June 5, 2025, Microbot Medical announced its selection for preliminary inclusion in the Russell Microcap® Index, as published by FTSE Russell on May 23, 2025. This inclusion, effective after the U.S. market closes on June 27, 2025, signifies a notable milestone for the company, potentially enhancing its visibility among investment managers and institutional investors who use Russell indexes as benchmarks for approximately $10.6 trillion in assets.

The most recent analyst rating on (MBOT) stock is a Buy with a $9.00 price target. To see the full list of analyst forecasts on Microbot Medical stock, see the MBOT Stock Forecast page.

More about Microbot Medical

Microbot Medical Inc. is a pre-commercial stage medical technology company focused on improving healthcare quality globally. It has developed the world’s first single-use, fully disposable endovascular robotic system, aiming to overcome traditional barriers to advanced robotic systems.

Average Trading Volume: 2,448,864

Technical Sentiment Signal: Buy

Current Market Cap: $99.31M

See more insights into MBOT stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1